Mount Sinai Health System — New York, New York

Mount Sinai Health System is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Mount Sinai Health System has participated in 39 clinical trials with 19 currently active.

Therapeutic areas: Multiple Myeloma, Endometrial Adenocarcinoma, Nodule Solitary Pulmonary.

Sponsors: Icahn School of Medicine at Mount Sinai, Acrivon Therapeutics, Biodesix, Inc..

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Health System?

Mount Sinai Health System has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Health System conducted?

Mount Sinai Health System has 39 clinical trials on record, with 19 currently active. Their work covers Multiple Myeloma, Endometrial Adenocarcinoma, Nodule Solitary Pulmonary.

Is Mount Sinai Health System accredited by Crixeo Health?

Yes — Mount Sinai Health System holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mount Sinai Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.